Recent and anticipated novel drug approvals (3Q 2024 through 2Q 2025).

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/E9DA331B.svg?ark=w1%2F20260526%2FE9DA331B&value=id)](https://nobleid.org/work/w1/20260526/E9DA331B)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors